All posts tagged "2009"

  • Financial
    Record Fourth Quarter Caps Strong Year for Medtronic

    MINNEAPOLIS–(BUSINESS WIRE)–Medtronic, Inc. (NYSE: MDT): “Across businesses and geographies, we have been executing against our strategy, resulting in a record $4 billion quarter” First $4 Billion Sales Quarter in Company History Full Year Revenue of $15.8 Billion Increased 8 Percent Full Year Non-GAAP Diluted EPS of $3.22 Grew 10%; GAAP Diluted EPS...

  • Financial
    Orthovita Reports 2009 Fourth Quarter and Year-End Financial Results

    MALVERN, Pa., Mar 10, 2010 (BUSINESS WIRE) — –Fourth quarter 2009 operating income of $385,000 compared to an operating loss of $670,000 in fourth quarter 2008; full year 2009 operating loss was $1.1 million compared to an operating loss of $9.2 million in 2008 –Fourth quarter 2009 net loss of $291,000, or...

  • Financial
    Osteotech Reports Fourth Quarter and Full Year 2009 Financial Results

    EATONTOWN, N.J., March 4 /PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE), a leader in the emerging field of biologic products for regenerative healing, today reported financial results for the fourth quarter and full year ended December 31, 2009. Results were in-line with the limited, preliminary financial results the Company released on January 14,...

  • Financial
    NuVasive Reports Fourth Quarter and Full Year 2009 Financial Results

    SAN DIEGO, Feb. 25 /PRNewswire-FirstCall/ — NuVasive, Inc. , a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today financial results for the quarter and for the full year ended December 31, 2009. NuVasive reported fourth quarter revenue of $106.9 million, a 43.4% increase...

  • Financial
    Greatbatch, Inc. Reports 2009 Fourth Quarter and Full Year Results

    CLARENCE, N.Y., Feb 23, 2010 (BUSINESS WIRE) — Greatbatch, Inc. (NYSE: GB), today announced results for its fourth quarter and year ended January 1, 2010: Sales for 2009 fourth quarter were $125.8 million and $521.8 million for the year. 2008 results include an additional week of operations. Adjusted operating margin of 13.1%...

  • Financial
    TranS1 Inc. Reports Operating Results for the Fourth Quarter of 2009

    Highlights: Fourth quarter revenues were $6.3 million 674 TranS1 procedures performed globally in the quarter Gross margin was 79.9% for the quarter GAAP loss per share was $0.28 for the quarter Non-GAAP loss per share was $0.25 for the quarter WILMINGTON, N.C., Feb. 23, 2010 (GLOBE NEWSWIRE) — TranS1 Inc. (Nasdaq:TSON), a...

  • Financial
    Alphatec Spine Announces Fourth Quarter and Full Year 2009 Revenue and Financial Results

    Annual Revenue of $132.2 Million — 30% Growth Vs 2008; 2009 Adjusted EBITDA of $15 Million CARLSBAD, Calif., Feb 23, 2010 (GlobeNewswire via COMTEX News Network) — Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical...

  • Financial
    Medtronic Third Quarter Revenue Increases 10% to $3.851 Billion; Raises Lower End of EPS Guidance for Current Fiscal Year

    MINNEAPOLIS, Feb 23, 2010 (BUSINESS WIRE) — –International revenue of $1.615 billion grew 11% on a constant currency basis; 22% as reported –Free cash flow exceeds $1.3 billion; GAAP cash flow from operations of $1.488 billion –Worldwide ICD revenue growth of 5% on a constant currency basis; 9% as reported –Worldwide CardioVascular...

  • Financial
    Exactech 2009 Revenue Up 10% to $177M; Q4 Revenue Up 20% to $48.3M, EPS $0.04 includes Charge to Earnings for Estimated DOJ Settlement

    GAINESVILLE, Fla., Feb 22, 2010 (BUSINESS WIRE) — Exactech, Inc. (EXAC 18.25, +0.15, +0.83%), a developer and producer of bone and joint restoration products for hip, knee, extremities, spine and biologic materials, announced today that revenue for 2009 increased 10% to $177.3 million from $161.7 million in 2008. Diluted earnings per share for the year...

  • Financial
    Orthofix International Announces Record Revenue in 4th Quarter 2009

    BOSTON, Feb 17, 2010 (BUSINESS WIRE) — –Q409 sales of spinal implants & biologics up 15% vs. prior year; sales of spine stimulation products grew 12% –Fourth quarter consolidated gross margin increased 80 basis points to 74.5%, –Operating margin increased to 15.3% –Spinal implants and biologic division achieves Q409 operating profitability –Q409...

  • Financial
    DJO Incorporated Announces Financial Results for Fourth Quarter and Fiscal Year 2009

    SAN DIEGO–(BUSINESS WIRE)–DJO Incorporated (“DJO” or the “Company”), a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its operating subsidiary, DJO Finance LLC (“DJOFL”), for the fourth quarter and fiscal year ended December 31, 2009. ReAble Therapeutics, Inc. (“ReAble”) acquired DJO...

  • Financial
    Smith & Nephew’s 2009 profits rise 15 percent to $723 million

    The British medical device maker’s profits last year rose to $723 million on flat sales of $3.8 billion; fourth-quarter sales rose 11 percent and Q4 profits were up 6 percent. Smith & Nephew plc (NYSE:SNN) closed out 2009 with a strong fourth quarter that saw the British medical device maker’s sales and...

  • Financial
    Theragenics® Reports Record Revenue with 2009 Results

    $78.3 Million is Highest Annual Revenue in 29-Year History Pro forma Organic Growth of 10% in Surgical Products Segment for 2009 Supply and Reseller Agreement with Core Oncology adds to Momentum for 2010 BUFORD, Ga.–(BUSINESS WIRE)–Theragenics Corporation (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets,...

  • Financial
    NeuroMetrix Reports 2009 Financial Results

    WALTHAM, Mass.–(BUSINESS WIRE)–NeuroMetrix, Inc. (Nasdaq: NURO), a health care company transforming patient care through neurotechnology, today announced its financial results for the three months and year ended December 31, 2009. Total revenues for the fourth quarter of 2009 were $6.2 million, compared with $7.2 million for the fourth quarter of 2008. Revenues...

  • Financial
    RTI Biologics Announces 2009 Year End, Fourth Quarter Results, Estimates 2010 Revenues and EPS

    ALACHUA, Fla.–(BUSINESS WIRE)–RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading processor of orthopedic and other biologic implants, reported operating results for the fourth quarter and full year ending Dec. 31, 2009. Quarterly Highlights: Revenues of $42.0 million, an increase of 12 percent over the prior year period Net income of $1.5 million,...

OrthoSpineNews is a publication run by Ortho Spine Companies which includes other brands like The De Angelis Group, Ortho Sales Partners, OrthoEx and Surg.io

Our desire is to provide valuable content to the industry we love in an easy to read manner.

Copyright © 2018 OrthoSpineNews.

Themed By teapots